Supplementary ExcelₙCounter PanCancer Human Pathways Panel Gene List from Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study
Key Points
Key points are not available for this paper at this time.
Abstract
Supplementary ExcelₙCounter PanCancer Human Pathways Panel Gene List
Supplementary ExcelₙCounter PanCancer Human Pathways Panel Gene List from Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study | Synapse